BDX - Becton, Dickinson and Company
NYSE
->
Healthcare
->
Medical Instruments & Supplies
Franklin Lakes,
United States
Type: Equity
BDX price evolution
BDX
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jul 2023 | 1 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1234 | $1481 | $1024 | $2068 |
| Short term investments | $2 | $8 | $8 | $6 |
| Net receivables | $2267 | $2534 | $2414 | $2413 |
| Inventory | $3304 | $3273 | $3588 | $3657 |
| Total current assets | $8156 | $8676 | $8588 | $9587 |
| Long term investments | ||||
| Property, plant & equipment | $6647 | $6557 | $6474 | $6356 |
| Goodwill & intangible assets | $35211 | $35470 | $35897 | $36457 |
| Total noncurrent assets | $44118 | $44104 | $44429 | $44807 |
| Total investments | $2 | $8 | $8 | $6 |
| Total assets | $52274 | $52780 | $53017 | $54394 |
| Current liabilities | ||||
| Accounts payable | $5524 | $4245 | $5021 | $5090 |
| Deferred revenue | ||||
| Short long term debt | $2016 | $1141 | $1856 | $2214 |
| Total current liabilities | $7540 | $6641 | $6878 | $7304 |
| Long term debt | $14094 | $14738 | $14926 | $16010 |
| Total noncurrent liabilities | $19402 | $20343 | $20202 | $21401 |
| Total debt | $16110 | $15879 | $16782 | $18224 |
| Total liabilities | $26942 | $26984 | $27080 | $28705 |
| Shareholders' equity | ||||
| Retained earnings | $15540 | $15535 | $15691 | $15563 |
| Other shareholder equity | -$1515 | $25796 | -$1507 | -$1575 |
| Total shareholder equity | $25332 | $25796 | $25937 | $25689 |
| (in millions $) | 30 Oct 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1481 | $1159 | $2392 | $2917 |
| Short term investments | $8 | $8 | $12 | $20 |
| Net receivables | $2534 | $2191 | $2497 | $2398 |
| Inventory | $3273 | $3224 | $2866 | $2743 |
| Total current assets | $8676 | $8141 | $8838 | $8969 |
| Long term investments | ||||
| Property, plant & equipment | $6557 | $6012 | $6393 | $5923 |
| Goodwill & intangible assets | $35470 | $36931 | $36684 | $37433 |
| Total noncurrent assets | $44104 | $44793 | $45028 | $45043 |
| Total investments | $8 | $8 | $12 | $20 |
| Total assets | $52780 | $52934 | $53866 | $54012 |
| Current liabilities | ||||
| Accounts payable | $4245 | $4304 | $4736 | $3993 |
| Deferred revenue | ||||
| Short long term debt | $1141 | $2179 | $500 | $707 |
| Total current liabilities | $6641 | $7811 | $6626 | $5836 |
| Long term debt | $14738 | $13886 | $17110 | $17224 |
| Total noncurrent liabilities | $20343 | $19841 | $23563 | $24411 |
| Total debt | $15879 | $16065 | $17610 | $17931 |
| Total liabilities | $26984 | $27652 | $30189 | $30247 |
| Shareholders' equity | ||||
| Retained earnings | $15535 | $15157 | $13826 | $12791 |
| Other shareholder equity | $25796 | -$1488 | -$2088 | -$2548 |
| Total shareholder equity | $25796 | $25282 | $23677 | $23765 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $4706 | $5087 | $4821 | |
| Cost of revenue | $2679 | $2586 | ||
| Gross Profit | $2027 | $1701 | $2235 | |
| Operating activities | ||||
| Research & development | $290 | $337 | ||
| Selling, general & administrative | $1213 | $1205 | ||
| Total operating expenses | $1589 | $1210 | $1608 | |
| Operating income | $438 | $627 | ||
| Income from continuing operations | ||||
| EBIT | $469 | $647 | ||
| Income tax expense | $77 | $27 | $68 | |
| Interest expense | $111 | -$105 | $118 | |
| Net income | ||||
| Net income | $281 | $108 | $461 | |
| Income (for common shares) | $281 | $438 | ||
| (in millions $) | 30 Oct 2023 | 31 Jan 2023 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $19372 | $17117 | ||
| Cost of revenue | $9540 | |||
| Gross Profit | $8170 | $7577 | ||
| Operating activities | ||||
| Research & development | $1096 | |||
| Selling, general & administrative | $4325 | |||
| Total operating expenses | $5732 | $6093 | ||
| Operating income | $1484 | |||
| Income from continuing operations | ||||
| EBIT | $1513 | |||
| Income tax expense | $132 | $111 | ||
| Interest expense | -$403 | $528 | ||
| Net income | ||||
| Net income | $1424 | $874 | ||
| Income (for common shares) | $767 | |||
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $281 | $407 | $461 | |
| Operating activities | ||||
| Depreciation | $561 | $571 | $563 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $83 | $56 | $56 | |
| Total cash flows from operations | $841 | $1081 | $185 | |
| Investing activities | ||||
| Capital expenditures | -$116 | -$191 | -$181 | |
| Investments | ||||
| Total cash flows from investing | -$233 | -$716 | -$329 | -$233 |
| Financing activities | ||||
| Dividends paid | -$275 | -$1114 | -$286 | -$282 |
| Sale and purchase of stock | -$500 | |||
| Net borrowings | -$1503 | $1661 | ||
| Total cash flows from financing | -$862 | -$1957 | -$1794 | $1369 |
| Effect of exchange rate | $7 | $5 | -$1 | $3 |
| Change in cash and equivalents | -$247 | $1851 | -$1043 | $1324 |
| (in millions $) | 30 Oct 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1779 | $2092 | $874 | |
| Operating activities | ||||
| Depreciation | $2229 | $2273 | $2154 | |
| Business acquisitions & disposals | -$2070 | -$508 | -$164 | |
| Stock-based compensation | $265 | $252 | $296 | |
| Total cash flows from operations | $2634 | $4647 | $3539 | |
| Investing activities | ||||
| Capital expenditures | -$973 | -$1231 | -$810 | |
| Investments | ||||
| Total cash flows from investing | -$716 | -$3231 | -$1880 | -$1232 |
| Financing activities | ||||
| Dividends paid | -$1114 | -$1082 | -$1048 | -$1026 |
| Sale and purchase of stock | -$500 | -$1750 | $2917 | |
| Net borrowings | -$78 | -$243 | -$1760 | |
| Total cash flows from financing | -$1957 | -$591 | -$3306 | $22 |
| Effect of exchange rate | $5 | -$45 | $15 | -$3 |
| Change in cash and equivalents | $1851 | -$1233 | -$525 | $2326 |
News
Fundamentals
| Market cap | $67.57B |
|---|---|
| Enterprise value | $82.44B |
| Shares outstanding | 288.90M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 2.52 |
| Book/Share | 92.93 |
| Cash/Share | 4.27 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.05 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.08 |
| Quick ratio | 0.64 |